Abstract The atrazine-specific single-chain variable antibody fragments (scFv) K411B was produced by expression in either the cytoplasm or the periplasm of Escherichia coli BL21(DE3). For periplasmic production, the pelB leader was N-terminally fused to scFv, whereas the unfused variant resulted in cytoplasmic expression. The extent of protein accumulation differed significantly. Expression of scFv with leader was 2.3 times higher than that of the protein without leader. This was further investigated by generating the respective translation profiles using coupled in vitro transcription/translation assays, the results of which were in agreement. This comparative approach was also applied to functionality: Periplasmic expression and in vitro expression resulted in only 10% correctly folded scFv, indicating that the oxidizing environment of the periplasm did not increase proper folding. Thus, the data obtained in vitro confirmed the findings observed in vivo and suggested that the discrepancy in expression levels was due to different translation efficiencies. However, the in vivo production of scFv with enhanced green fluorescent protein (EGFP) fused C-terminally (scFv-EGFP) was only successful in the cytoplasm, although in vitro the expression with and without the leader rendered the same production profile as for scFv. This indicated that neither the translation efficiency nor the solubility but other factors impeded periplasmic expression of the fusion protein.
Introduction
Many factors involved in protein folding, translation and transcription may limit the efficient expression of heterologous proteins in Escherichia coli. This is particularly true for eukaryotic proteins, such as single-chain variable antibody fragments (scFv's), which may require posttranslational modification to exert their proper action. The pros and cons of periplasmic and cytoplasmic expression of antibody fragments in E. coli have been intensively discussed (Martineau et al. 1998; Wulfing and Pluckthun, 1994) .
On the one hand, secretion of scFv into the periplasm seems to be a very promising strategy, because the oxidizing environment allows the efficient formation of disulfide bonds. Disulfide bonds do not form in the cytosol (Bessette et al. 1999) . Therefore cytoplasmic expression of scFv's frequently leads to the formation of inclusion bodies due to the aggregation of malfolded protein. Refolding of these inclusion bodies can be achieved (Sanchez et al. 1999) . On the other hand, toxic effects and formation of periplasmic aggregates may counteract the high-level expression of active protein in the periplasm (Wulfing and Pluckthun, 1994 ).
However, high-level cytoplasmic expression of active scFv's is also possible. Tavladoraki et al. were able to show that a scFv folded correctly in the reducing environment of the cytoplasm even without the formation of disulfide bridges (Tavladoraki et al. 1999) . In other cases, scFv's have been engineered by random mutagenesis to fold correctly in the cytoplasm (Martineau et al. 1998) . Therefore, it can be concluded that it is the intrinsic properties of the protein that determine which of the above-mentioned expression strategies are most suitable for the production of a specific scFv.
Besette et al. improved the folding of proteins with disulfide bonds by altering the natural set of thioredoxins and co-expressing the protein disulfide isomerase DsbC in the cytoplasm. They found that originally secreted proteins could thus be folded efficiently in the cytoplasm (Bessette et al. 1999) . Improvements in the folding of heterologous proteins in the presence of chaperones and/ or folding catalysts have been achieved in cell-free translation (Ryabova et al. 1997) as well as in E. coli (Georgiou and Valax, 1996; Wall and Pluckthun 1995) . However, some of these proteins need to be expressed in stoichiometric amounts and co-expression of additional proteins complicates production with regard to plasmid stability and induction; therefore, the potential to produce the target protein is decreased.
Studies comparing in vivo and in vitro expression of scFv's have shown that certain scFv's can be expressed well in vitro but only in small quantities in vivo (Merk et al. 1999) . By comparing the expression levels and ratios of active and inactive recombinant protein in both systems, it should be possible to identify factors that limit the functional expression of scFv's in vivo. Such drawbacks are due to transcription and translation, the physico-chemical properties of the environment, or global physiological effects. Some aspects of functional expression, such as transcription efficiency, translation efficiency and spontaneous protein folding, occur both in vitro and in vivo, while translocational events or toxic effects appear only in vivo.
In the present report, factors that limit the expression of heterologous protein were studied using constructs of the atrazine-specific scFv K411B (Kramer and Hock, 1996) . This scFv contains two disulfide bonds and can be applied for the detection of the herbicide atrazine in ground water and drinking water. Expression of scFv with and without an N-terminal pelB leader sequence was compared in E. coli. In addition, the influence of Cterminal fusion of EGFP to the scFv was investigated.
Materials and methods

Microorganisms and growth conditions
Escherichia coli DH5a (Hanahan 1983 ) was used for cloning and plasmid propagation, E. coli BL21(DE3) (Novagen, Madison, Wis.) for protein expression. Plasmids destined for in vitro expression were prepared in E. coli JM109. Cells were cultivated at 37 C or 30 C in Luria broth (LB) or synthetic medium (Wilms et al. 2001) , each supplemented with 100 mg l -1 (m v -1 ) carbenicillin. For the expression of recombinant protein, shake-flask cultures were inoculated 1:100 with overnight cultures, induced with a final concentration of 1 mM isopropyl b-d-thiogalactopyranoside (IPTG) at an OD 600 of 1.0-1.2 and harvested after 4 h of incubation at 30 C.
Plasmids and primers
The plasmid pCANTAB 5E, carrying the gene for scFv K411B, was used (Kramer and Hock 1996) . pET20b(+) was purchased from Novagen (Madison, Wis.). pEGFP, containing the sequence coding for EGFP, was purchased from Clontech (Palo Alto, Calif.). Primers were supplied by ARK (Darmstadt, Germany) or MWGBiotech (Ebersberg, Germany). The following three plasmids were used as control plasmids in the in vitro experiments: pIVEX2.1-gfp (carrying a gene coding for EGFP) was purchased from Roche (Mannheim, Germany). pTST101 and pBW8 (carrying genes coding for a MalE-EGFP fusion protein and a homotetrameric hydantoinase, respectively) were kindly provided by Dr. Josef Altenbuchner (Institute of Industrial Genetics, University of Stuttgart, Germany). Plasmids used for in vitro studies were purified using the Plasmid Maxi-Kit (QIAGEN, Hilden, Germany).
Cloning procedures
The gene coding for the scFv K411B in pCANTAB 5E was amplified by PCR using the primers 5'-ACTGATATCTCCATG-GTCCAGGTGAAACTGCAGCAG-3' and 5'-GCAGTCGAC-GAATTCCCGTTTGATTTCCAGCTT-3', which introduced the restriction sites NcoI at the 5' end and SalI at the 3' end of the gene. PCR amplifications were carried out in a Robocycler gradient 40 (Stratagene, Amsterdam, Netherlands). The purified 777-bp PCR product was cut with NcoI and SalI, repurified, and ligated into pET20b(+), cut with the same restriction enzymes. The plasmid pETK(+) contained the gene encoding the scFv K411B with a pelB leader at the N-terminus and a His 6 -tag at the Cterminus. To obtain pETK(), in which the sequence coding for the pelB leader sequence was deleted to allow cytoplasmic expression, pETK(+) was digested with NdeI and NcoI, followed by Klenow fill-in and blunt-end religation of the 4,369-bp fragment. To generate pETKE(+) and pETKE(), pETK(+) and pETK() were digested with SalI, pEGFP with NcoI. After Klenow fill-in, the linearized plasmids were digested with NotI; the resulting 724-bp pEGFP fragment was ligated with the linearized plasmids pETK(+) and pETK(), respectively. The resulting plasmids, pETKE(+) and pETKE(), contained the gene coding for the fusion protein, consisting of the scFv gene followed directly in-frame by the EGFP gene, with and without the pelB leader sequence at the 5'-terminus. To restore the original number of nucleotides between the ShineDalgarno sequence and the start codon, two additional nucleotides that had been inserted upstream of the start codon in pETK() and pETKE() were removed using the QuikChange PCR kit (Stratagene, Amsterdam, Netherlands), resulting in pETK()-AC and pETKE()-AC. PCR was carried out according to the manufacturers' instructions using the forward primer 5'-GAAGGAGATATA-CATATGGTCCAGGTGAAAC-3' and the corresponding reverse primer with the complementary sequence, followed by DpnI digestion, dialysis against water and transformation. Analogously, two control plasmids, pETK(+)+AC and pETKE(+)+AC, containing two extra nucleotides were created with the forward primer 5'-GAAGGAGATATACATACATGAAATACCTGCTG-3' and the corresponding reverse primer. Plasmids were transformed into E. coli DH5a or BL21(DE3) by a heat-shock method (Chung et al. 1989) or by electroporation (Sambrook et al. 1989) (Gene Pulser and Pulse Controller, Bio-Rad, Munich, Germany) . Transformed cells were grown overnight at 37 C on LB agar plates containing carbenicillin. The plasmids pETK(+), pETK(), pETKE(+) and pETKE() and the translation initiation regions of all of the plasmids are shown in Fig. 1 . DNA sequencing DNA was sequenced using the fluorescence-based dideoxy DNA cycle method, primers between 18 and 24 nucleotides in length, the Terminator Ready Reaction Mix with Ampli-Taq-Fs (Perkin Elmer, Wellesly, Mass.), and a 377 DNA sequencing system (Applied Biosystems, Weiterstadt, Germany).
Coupled in vitro transcription/translation
Coupled cell-free protein biosynthesis was carried out using an S30 bacterial cell extract system generated from E. coli A19 according to the method of Pratt (1984) with minor modifications as previously described (Schindler et al. 2000) . Batch-wise cell-free transcription/translation was done at 30 C as reported (Schindler et al. 1999 (Schindler et al. , 2000 . The reaction mixture contained the respective plasmid at a final concentration of 5.6 nM, 2 kU ml -1 T7-RNA polymerase, 48 mg ml -1 (m v , Amersham Pharmacia Biotech, Little Chalfont, UK) was added to the standard mixture. At respective times, 4-l aliquots were withdrawn and the protein concentration determined by liquid scintillation counting as described previously (Arnold 2001) . Aliquots of the reaction mixture were further analyzed by SDS-PAGE followed by autoradiography according to the method of Katanaev et al. (1996) . In order to separate soluble and insoluble protein fractions, the entire reaction mixture was centrifuged at 10,000 g for 20 min prior to analysis as described in Katanaev et al. (1996) . The autoradiographs were scanned and further analyzed using the ImageMaster VDS-software, package 2.0 (Amersham Parmacia Biotech). The amount of protein synthesized in vitro was quantified by comparison with external calibration standards of 0-100 M of radiolabeled 14 C-Leu.
Cell disruption and sample preparation E. coli BL21(DE3) cells from shake-flask cultures or the bioreactor were harvested by centrifugation (3,000 g, 4 C, 10 min). Total, periplasmic, and cytoplasmic extracts were prepared as suggested by the supplier (Novagen). Cytoplasmic extracts were obtained from protoplasts after periplasmic extraction. The insoluble fraction contained the resuspended pellet after cytoplasmic extraction and centrifugation. The resulting cell fractions were either used directly for SDS-PAGE or cell debris was removed by centrifugation to separate insoluble from soluble protein. The resulting samples were analyzed using SDS-PAGE, enzyme-linked immunosorbent assay (ELISA), fluorophor-linked immunosorbent assay (FLISA), and the BCA Protein Assay Kit (Pierce, Rockford, Ill.) or the Bio-Rad Protein Assay Kit following the instructions of the manufacturers. For these assays, normalized amounts of extract, always corresponding to the same volume of the original cultivation broth, were applied.
SDS-PAGE, blotting, and N-terminal sequencing of proteins
Protein samples were separated by SDS-PAGE in 12.5% (m v -1 ) polyacrylamide gels (Laemmli 1970 ) and either stained with Coomassie brilliant blue R-250 or electro-blotted onto a PVDF membrane (Sequi-Blot PVDF Membrane, Trans-Blot SD, Semi-dry transfer cell, Bio-Rad, Hercules, Calif.) as described (Coull et al. 1991; Matsudaira, 1987) . The protein of interest was excised from the stained membrane and sequenced N-terminally using a gasphase sequencer (Procise 491 Protein Sequencer, 785 Programmable Absorbance Detector, 140C Microgradient System, Applied Biosystems).
ELISA and FLISA
The amount of active scFv in samples was monitored by noncompetitive hapten-immobilized ELISA as described recently (Oelschlaeger et al. 2002) . Since at higher concentrations of scFv the ELISA signal showed saturation, the slope in the linear range was taken as an approximation for the amount of functional scFv.
The amount of bifunctional scFv-EGFP fusion protein was determined by hapten-immobilized non-competitive FLISA as reported (Oelschlaeger et al. 2002) . In this assay, the EGFP portion of the fusion protein is directly used as an indicator of the amount of bound fusion protein. Since no saturation was observed in this assay, FLISA signals could be used directly for quantification of functional fusion protein.
Microscopy
IPTG-induced cells were examined by light microscopy and fluorescence microscopy using a Leica DMIRBE microscope (Leica Microsystems, Wetzlar, Germany) and an HCX PL Apo 63x/1.32-0.6 oil immersion objective. The fluorescence setup was: excitation at 488 nm with Polychrome 2 (TILL Photonics, Munich, Germany) and a F53-009 dichroic mirror (AHF Analysentechnik, Tuebingen, Germany). Emission was measured with a 535/50 nm bandpass filter (AHF Analysentechnik). Images were taken with a Hamamatsu Orca C4742-95 camera (Hamamatsu Photonics K.K., Hamamatsu, Japan) and processed with Openlab 2 (Improvision, Coventry, UK).
Induced cells were harvested by centrifugation after 2 h at 30 C, washed in 80 mM PBS buffer, and resuspended (5concentrated) in 2% (m v -1 ) paraformaldehyde in 80 mM PBS. After a 20-min incubation at 37 C, the cells were centrifuged and resuspended (10concentrated) in embedding medium and used for microscopy.
Results
Strategy for the detection of factors that limit heterologous expression of scFv K411B and the respective scFv-EGFP fusion protein in E. coli
The genes coding for two proteins, the atrazine-specific antibody fragment scFv K411B and the fusion protein of the respective scFv and a C-terminal EGFP, were cloned into pET20b(+) for periplasmic and cytoplasmic expression in E. coli BL21(DE3). The following vector plasmids were generated: Fig. 1 Plasmids. The structures of the four investigated constructs are depicted schematically at the top. PT7 T7 promoter, sd Shine Dalgarno sequence, pelB pelB leader sequence, his poly-histidine tag sequence. The sequences of the ribosome binding sites of the four constructs and control plasmids are shown at the bottom. tic translation initiation codon 1. pETK(+): The scFv K411B gene was inserted in-frame between an N-terminal pelB leader sequence and a C-terminal His 6 -tag of the vector plasmid pET20b(+). 2. pETK(): The coding sequence of the pelB leader was deleted from pETK(+). 3. pETKE(+):The EGFP gene was fused to the C-terminus of the scFv K411B gene of pETK(+). 4. pETKE(): The EGFP gene was fused to the C-terminus of the scFv K411B gene of pETK().
The coding regions of the plasmids are shown in Fig. 1 . In order to test whether the insertion of two extra nucleotides upstream of the start codon (inserted as a consequence of the cloning procedure) had an effect on translation efficiency, plasmids pETK()-AC and pETKE()-AC, in which the original sequence between the Shine-Dalgarno sequence and the start codon was restored, were constructed. As a negative control for the vectors coding for the precursors, two extra nucleotides were inserted into pETK(+) and pETKE(+) upstream of the start codon, resulting in plasmids pETK(+)+AC and pETKE(+)+AC.
In vivo expression of scFv with and without the pelB leader and of the scFv-EGFP fusion protein without the pelB leader E. coli BL21(DE3) cells were transformed with the four plasmids described above. The strain transformed with pETKE(+) could not be cultivated. The cells transformed with the other three plasmids were induced, harvested, and cell extracts were prepared to investigate the total expression levels and the accumulation of functional protein in different cell compartments. The phenotypic appearance of induced cells from all three strains was examined by light microscopy. In addition, the strain expressing the scFv-EGFP fusion protein without leader sequence was examined by fluorescence microscopy.
The relative amount of heterologous scFv was estimated by SDS-PAGE of total cell lysates (Fig. 2) . For pETK(+) (lane 2), a clear band of 29 kDa, which corresponds to the calculated size of the mature scFv, was obtained after expression of scFv with the pelB leader sequence. For pETK() (lane 4), a band of identical molecular weight was observed resulting from the expression of the scFv without pelB, suggesting that the pelB leader sequence of the scFv precursor had been cut off and translocation had occurred (lane 2). This was confirmed by N-terminal sequencing. Densitometric evaluation of the bands in lanes 2 and 4 indicated that the accumulation of scFv expressed in the periplasm was 2.3-fold greater than that of scFv expressed in the cytoplasm.
Equivalent volumes of: (1) the culture supernatant (corresponding to the extracellular fraction), (2) the soluble fraction of the periplasmic extract, (3) the soluble fraction of the cytoplasmic extract (prepared from protoplasts separated by centrifugation after periplasmic extraction), and (4) the resuspended pellet, which contained insoluble protein of both cell compartments and the culture supernatant, were applied to ELISA in order to determine the localization of active scFv (Table 1 ) and the , no activity was detectable in the medium and almost none in the periplasmic fraction (1.0%). The activity was higher in the cytoplasm (92.5%) and much lower in the pellet (6.5%) compared to the strain expressing scFv with pelB. The corresponding percentages of protein were 2.9% (extracellular fraction), 4.1% (periplasm), 75.9% (cytoplasm) and 17.1% (pellet). The high protein content in the pellet was mainly due to an uncharacterized protein of~32 kDa.
Results obtained with cells expressing the scFv-EGFP fusion protein or scFv without pelB leader were similar to those with cells expressing the scFv without leader. Binding activity of the scFv domain, measured by FLISA, was found only in the soluble fraction of the cytoplasm (69.0%) and the pellet (31.0%). These fractions contributed 44% and 33%, respectively, to the total cell protein. Fluorescence could also be detected in the medium and the periplasmic fraction, but as no binding activity could be observed, the signals were certainly not emitted by the bifunctional fusion protein.
It has to be kept in mind that only a small portion of the protein in the pellet was active, probably due to spontaneous refolding upon resuspension, and the total amount of protein was much higher than suggested by the measured activities. We assume that soluble scFv is correctly folded and active. SDS-PAGE and activity measurement of soluble and insoluble fractions of cells expressing scFv with pelB leader in a fed-batch cultivation (data not shown) indicated that the ratio soluble/ insoluble scFv was~1:10 and the activity was comparable in both fractions. Thus, the ratio amount of active scFv/ total amount of scFv can be estimated as 1:1 in soluble fractions and as 1:9 (~10%) in insoluble fractions.
The phenotypes of BL21(DE3) cells expressing the scFv with the pelB leader [pETK(+)] and BL21(DE3) cells transformed with the empty vector pET20b(+) were comparable as determined by light microscopy (Fig. 3A,  B) . Clear periplasmic inclusion bodies were not observed, indicating that insoluble processed scFv was evenly distributed in the periplasm. For cells expressing the scFv and the scFv-EGFP fusion protein without leader [pETK() and pETKE()], however, knobs were visible at one or either end of the cylindrically shaped cells (Fig. 3C, D) . These knobs probably consisted of cytoplasmic inclusion bodies of malfolded recombinant protein. Fluorescence microscopy of cells expressing mature scFv-EGFP [pETKE()] (Fig. 3E) showed that intense fluorescence coincided exactly with these knobs. Obviously, this protein was aggregated, probably mainly due to the malfolded scFv domain, but the EGFP domain conferred some fluorescence. GFP expressed alone has been shown to fold correctly in the cytoplasm and to give bright fluorescence all over the cell in fluorescence microscopy (Cha et al. 2000) . In vitro expression of scFv and scFv-EGFP fusion protein with and without pelB leader All four plasmids were successfully expressed in vitro (cell-free coupled transcription/translation). The accumulation of protein and the ratios of soluble and insoluble protein were determined and compared to the in vivo results.
The in vitro expression of pETK(+) with the pelB leader sequence resulted in a final concentration of 19 g protein ml -1 , which was 2.7-fold higher than the amount obtained for the plasmid pETK() (7 g ml -1
) lacking the respective leader sequence (Fig. 4A) . A similar ratio was obtained for the in vitro expression of pETKE(+) and pETKE() (24 and 10 g ml -1 , respectively, Fig. 4B ). The data indicate that the C-terminal fusion of EGFP to scFv does not significantly influence the expression level, whereas the N-terminal fusion of the pelB leader sequence does.
According to Ringquist et al. (1992) , the number of nucleotides between the Shine-Dalgarno sequence and the start codon might be responsible for the observed differences. However, pETKE()-AC and pETK()-AC showed virtually the same expression levels as pETKE() Samples were loaded onto SDSpolyacrylamide gels after 60 min of coupled in vitro transcription/translation synthesis and autoradiographed. The molecular masses (in kDa) of the proteins are indicated on the left and the right. S (supernatant) and P (pellet) indicate the soluble and insoluble fractions of each batch reaction, respectively. pIVEX2.1-gfp, pBW8, and pTST101 are control plasmids and pETK(), whereas the insertion of the two respective nucleotides in pETK(+)+AC and pETKE(+)+AC led to a 25% decrease in productivity compared to the expression of pETK(+) and pETKE(+) (data not shown). Thus, the highest protein yields were obtained for pETK(+) and pETKE(+). These yields were in the same range as those obtained for the three control plasmids pTST101, pBW8, and pIVEX2.1-gfp [~25 g ml -1
, (Arnold et al. 2001; Schindler et al. 2000) ]. These plasmids encode a MalE-EGFP fusion protein, a homotetrameric hydantoinase, and EGFP under control of the T7 promoter, respectively.
The soluble and insoluble fractions of the expressed proteins were separated by centrifugation and subsequently applied to SDS-PAGE (Fig. 5) ; the intensities of the bands corresponding to the expressed proteins were monitored by autoradiography. For the plasmids pETK(+), pETK(), pETKE(+) and pETKE(), the amounts of soluble protein were 8%, 15%, 12% and 10%, respectively. Given the accuracy of autoradiographic evaluations, the variation found in these figures was not considered significant. These data show that neither the N-terminal fusion of the pelB leader sequence nor the Cterminal fusion of EGFP influence the folding of the resulting proteins in vitro. The ratios of soluble protein were much lower than those obtained when expressing the control plasmids pTST101 (94%), pBW8 (60%) and pIVEX2.1-gfp (96%). The proteins encoded by these plasmids do not have intra-domain disulfide bonds.
Discussion
Cytoplasmic vs periplasmic expression
The scFv K411B gene codes for an atrazine-specific antibody fragment, a protein with two disulfide bonds that can be applied for detection of the herbicide in both ground and drinking water (Kramer and Hock 1996) . This gene was heterologously expressed in E. coli with and without the pelB leader sequence [pETK(+) and pETK()] and with and without the C-terminal fusion of the EGFP gene [pETKE() and pETK()]. In doing so, it was observed that the yields of total and functional protein differed for the respective constructs. The total expression level and the expression level of functional protein were compared for scFv with and without pelB leader sequence. In vivo, the total amount of scFv accumulated after expression of the scFv with pelB leader [pETK(+)] was 2.3-fold higher, and the total activity 1.6-fold higher than after expression of scFv without leader [pETK()] when summing up the activities measured in different fractions after cell extraction.
The major portion of the precursor was translocated into the periplasmic space and processed to mature protein (verified by N-terminal sequencing), followed either by partial cell lysis or secretion of scFv into the culture supernatant. Most of the protein in the periplasm formed insoluble periplasmic protein that was found in the pellet (insoluble fraction) after the cell extraction procedure. However, no periplasmic inclusion bodies were visible by light microscopy. In contrast, Kipriyanov et al. reported the formation of periplasmic inclusion bodies (Kipriyanov et al. 1995) . In our case, the heterologous protein might have formed small aggregates, which are not visible by light microscopy. A relatively small fraction of active scFv was present in the soluble fraction of the cytoplasmic extract, whereas the majority of the protein was found in the pellet. This protein gave a signal in ELISA, which was surprising because ELISA data represent only active protein. Probably this observation was due to spontaneous refolding.
No translocation into the periplasm occurred in cells expressing scFv and scFv-EGFP fusion protein without leader [pETK() and pETKE()]. In contrast to scFv with leader [pETK(+)], the amount of active protein in the soluble fraction of the cytoplasmic extract was significantly higher than that in the resuspended pellet. For scFv and the scFv-EGFP fusion protein without leader [pETK() and pETKE()], the soluble cytoplasmic fraction constituted 92.5% and 69.0% of the total activity, respectively. As the cytoplasm of E. coli does not favor disulfide bond formation, it is likely that scFv and scFv-EGFP in the cytoplasmic fraction and the pellet obtained activity by spontaneous refolding and oxidation during sample preparation and during resuspension in lysis buffer, respectively. Inclusion bodies contributing~5% to the total cell volume were observed by microscopy of living cells expressing the proteins without leader. This is in good agreement with the percentage of the total recombinant protein as determined by SDS-PAGE (Fig. 2,  lane 4) and supports the possibility of spontaneous refolding after cell disruption. Although periplasmic aggregates were also present during preparation of the cytoplasmic extract of cells expressing the scFv in the periplasm and the total expression level of this protein was higher, the relative activity of the soluble cytoplasmic fraction was small (42.8%). The observations suggest that cytoplasmic aggregates renature more easily in lysis buffer than do periplasmic aggregates. This might be due to missing disulfide bond formation in cytoplasmic expression and erroneous disulfide bond formation in periplasmic expression. To test this assumption, we remeasured the activity in the fractions from the expression of scFv with and without pelB leader after incubation at 20 C for 3 days. Whereas the relative activities in the soluble cytoplasmic fraction and in the resuspended pellet remained almost the same for periplasmic expression (44.9% and 46.8% after 3 days compared to 42.8% and 44.7% immediately after sample preparation), they changed significantly for cytoplasmic expression (61.2% and 35.4% compared to 92.5% and 6.5%), possibly due to further spontaneous refolding of the cytoplasmic inclusion bodies. The malfolded scFv from periplasmic aggregates could not be further renatured in lysis buffer, but renatured with good yields following a procedure similar to that reported by Buchner et al. (1992) , which includes reduction and re-oxidation (data not shown). Once the scFv had obtained its native state, it proved to be very stable and still showed good activity after 1 year of storage at 4 C.
Analysis of expression by comparison with in vitro results
Many factors influence the in vivo expression of recombinant protein. However, some of these effects can only be seen in vivo, while others occur in vivo and in vitro. The former are defined as "physiological effects" (complex posttranslational events such as translocation inside the cell, processing, assisted protein folding, protein degradation, and toxic effects), which only occur in the living cell, but not or to a much lower extent in cell extracts. In contrast, the latter are considered "intrinsic effects" (transcription and translation efficiency and spontaneous protein folding), which depend on intrinsic properties of the nucleotide sequences of the DNA and mRNA and on the amino acid sequence of the expressed protein.
In vivo protein folding is not completely understood, but certainly depends both on intrinsic properties of the protein, which are stipulated by the amino acid sequence, and on physiological effects. These include the redox potential of the environment and the presence of folding catalysts, which influence the formation of disulfide bridges, and chaperones, which may assist the proper folding of certain proteins. In the expression system used here, intrinsic effects were reduced to the translation efficiency and the spontaneous protein-folding problem, because derivatives of the vector plasmid pET20b(+) are high-copy plasmids and the T7-promoter expression system is so efficient that mRNA is synthesized much faster than it can be translated by the typical set of ribosomes in E. coli. However, this overproduction of mRNA may lead to secondary structures, which are of minor importance in natural prokaryotic expression systems in which transcription and translation are directly coupled.
In the following discussion, we attempt to assign the experimentally observed data to either physiological or intrinsic effects. As stated earlier, data obtained in vitro correspond to intrinsic effects, and data obtained in vivo are the result of intrinsic and physiological effects. We investigated the relative expression level and the solubilities of heterologous protein. Since the measurements, in particular in the in vivo system, are not very precise, the observed data were classified as high (>66%), moderate (66-16%), or low (<16%), with 100% indicating the optimal observed protein accumulation (in vivo~10% of total cell protein, in vitro 24 g proteinml -1 ) and 100% of soluble/functional protein. While this classification might seem arbitrary, values within one class are at least twice as high as values in the next lower class. Table 2 summarizes the in vitro and in vivo results for the extent of accumulated scFv and scFv-EGFP fusion protein with and without pelB leader sequence, respectively. The excellent concordance of the in vitro and in vivo data for scFv with and without leader and scFv-EGFP without leader suggests that the different extents of accumulation observed in vivo reflect intrinsic effects. Due to the efficient promoter and the fact that the amino acid sequence influences the structure, but not the expression level of a protein, these intrinsic effects can be assigned specifically to the nucleotide sequence of the mRNA and to the translation efficiency. By comparing the amounts of accumulated recombinant protein for pETK(+) and pETKE(+) with pETK() and pETK()-AC as well as with pETKE() and pETKE()-AC, it can be shown that the two extra nucleotides directly upstream of the start codon had no influence on translation efficiency; this is in contrast to observations made by Ringquist et al. (1992) .
Accumulation of heterologous protein
A plausible explanation for the low expression levels of the genes without the leader sequence might be the presence of the codon GUC at the +2 position (the codon directly downstream of the start codon). In the constructs containing the pelB leader sequence, the +2 codon is AAA, which is the most common codon at this position in E. coli and leads to higher gene expression levels than do most other codons (Gren 1984; Stenstrom et al. 2001a ). The codon usage in this region seems to be important for the initiation of translation (Stenstrom et al. 2001b ). Furthermore, the secondary structure of the mRNA of the constructs without the pelB leader sequence might have an impact on mRNA recognition by the ribosome and therefore suppress the negative effect of the two additional nucleotides. This is under further investigation and will be published elsewhere.
Severe problems occurred with the in vivo expression of the scFv-EGFP fusion protein with leader sequence. As it could be expressed at high levels in vitro (24 g ml -1 ), this problem can be attributed clearly to physiological effects. Such problems have been discussed elsewhere (Casey et al. 2000; Griep et al. 1999) , and toxic effects of other EGFP fusion proteins have been described (Feilmeier et al. 2000) .
Solubility and functionality
The solubilities of the recombinant proteins are classified in Table 3 . For the in vivo experiments, the solubilities refer to the ratio of active to inactive protein after sample preparation, which might not reflect the situation in the living cell because spontaneous refolding might have occurred after cell disruption. However, whether a protein can be refolded spontaneously after isolation from the cell may depend on its processing inside the cell. For the scFv with leader sequence, the in vivo data correspond to the in vitro data and only approximately 10% of recombinant protein was soluble. Consequently, and according to our classification scheme, the low percentage of soluble protein observed in periplasmic expression reflects an intrinsic effect. Too rapid gene expression or volume limitations can be excluded, because other proteins have been expressed at higher levels in vitro and with approximately 100% soluble protein (Arnold et al. 2001 , Schindler et al. 2000 . In cellfree coupled transcription/translation, no efficient oxidation and formation of disulfide bonds is possible, which is necessary for most scFv's to fold correctly. Directly after the experiment, the insoluble protein was separated by centrifugation, not allowing any further spontaneous refolding. In vivo expression of scFv into the oxidizing environment of the periplasm did not increase the percentage of soluble protein. Here, oxidization might have occurred for the major portion of scFv, but in an erroneous manner. For cytoplasmic expression, relatively high amounts of active scFv (~60%) and scFv-EGFP (~20%) were observed after sample preparation based on comparison of relative activities in soluble and insoluble fractions (Table 1) . Since in vitro expression yielded only 10% soluble protein, it is reasonable to assume that, in vivo, initially also the majority of the recombinant protein was malfolded in the non-oxidizing cytoplasm, which was undermined by microscopic observations. However, in contrast to periplasmic expression, the heterologous protein seemed to be kept in a state that could be more easily refolded to the native state during sample preparation. This included the use of the detergent Triton X-100, incubation with lysozyme under shaking, and sonification. During these steps, some of the protein might have been refolded and oxidized to its native state. As this procedure did not result in a comparable increase of activity for periplasmic aggregates, although the total amount of scFv was higher, we assign this observation to physiological effects.
Conclusions
We have shown that quantitative comparison of in vitro and in vivo expression of scFv and an scFv-EGFP fusion protein allows the identification of factors that impede high-level protein production in E. coli. Once identified, these factors can be partially eliminated by appropriately adjusting the conditions for expression. Here, translation efficiency, which is influenced by the mRNA sequence, was a limiting factor. Optimization of the nucleotide sequence with regard to the formation of secondary mRNA structures is under further investigation. The formation of insoluble protein could be assigned to intrinsic properties of the protein, although spontaneous refolding into the native state seemed to be favored after expression in the cytoplasm. However, in order to directly obtain all heterologously expressed scFv in a soluble form, protein engineering or the use of genetically engineered strains as described by Besette et al. (1999) might be necessary. The failure to obtain in vivo expression of the scFv-EGFP fusion protein with the pelB leader was likely due to physiological effects, because the construct was expressed well in vitro.
As many recombinant proteins are expressed either very poorly or in an inactive form in E. coli, a combination of in vitro and in vivo expression may help to identify factors impeding expression. Here, the in vitro assay could adequately reproduce the in vivo expression levels and, therefore, might be a practicable tool to screen for good expression vectors before developing an in vivo expression system. 
